CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dimension Therapeutics, Inc. (“Dimension” or the “Company”), a leading rare disease company advancing novel, liver-directed treatments for diverse genetic disorders, ...
An introduction to ELEVATE for Veterans-Only Program at Dimensions Algonquins Highlands. TORONTO, June 07, 2023 (GLOBE NEWSWIRE) -- Dimensions, has announced that Veterans Affairs Canada (VAC) has ...
Activities have commenced for 3 gene therapy programs in rare disease indications Aptuit LLC, a premier global drug discovery and development CRO, and Dimension Therapeutics, a biopharmaceutical ...
Aptuit LLC, a premier global drug discovery and development CRO, and Dimension Therapeutics, a biopharmaceutical company advancing novel, adeno-associated virus (AAV) gene therapies targeting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results